Cargando…
Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling
Cisatracurium besilate is the most commonly used non-depolarizing muscle relaxant in general anesthesia and in intensive care units. Studies have indicated that the proliferation of gastric cancer (GC) cells can be restrained by cisatracurium besilate. The present study aimed to investigate the mech...
Autores principales: | Zhou, Qiang, Yuan, Jianxia, Liu, Yi, Wu, Yayun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810161/ https://www.ncbi.nlm.nih.gov/pubmed/34845969 http://dx.doi.org/10.1080/21655979.2021.2009318 |
Ejemplares similares
-
Baricitinib/cisatracurium besilate: Rhabdomyolysis: case report
Publicado: (2021) -
Continuously protracted infusion of cisatracurium besilate in patients with ARDS
por: Yuan, Ziming, et al.
Publicado: (2022) -
Cisatracurium-besilate: ICU-acquired weakness: case report
Publicado: (2022) -
Cisatracurium besilate/dexamethasone/remdesivir: Malignant hyperthermia and lack of efficacy: case report
Publicado: (2021) -
Facial Nerve Monitoring under Different Levels of Neuromuscular Blockade with Cisatracurium Besilate in Parotid Tumour Surgery
por: Huang, Huimin, et al.
Publicado: (2021)